Skip to main content
. 2016 Oct 31;11(10):e0165609. doi: 10.1371/journal.pone.0165609

Table 2. Clinicopathologic characteristics of the patients.

Disease Histology Training set (n = 268) Validation set (n = 156)
No. of Patients FIGO (No. of patients) Age (years) No. of Patients FIGO (No. of patients) Age (years)
I II III IV unknown Range Median Mean I II III IV unknown Range Median Mean
Ovarian disease 230 93
Benign tumor 114 22–81 44.5 47.5 40 20–76 42.5 42.8
EMS 71 28–71 43 44.2 17 23–57 44 41.4
non-EMS 43 22–81 54 52.9 23 20–76 41 43.9
Borderline tumor 8 8 0 0 0 0 31–75 53 55.8 15 14 0 1 0 0 16–80 46 47.6
Ovarian cancer 108 38
CCC-subtype 29 15 3 8 3 0 37–79 57 56.7 7 3 1 3 0 0 38–71 58 57.7
non-CCC-subtypes 79 22 12 25 16 4 15–84 57 55.0 31 8 4 11 6 2 27–84 63 61.5
Serous 27 3 2 14 8 0 15–79 58 55.2 17 3 2 9 2 1 36–76 65 63.3
Endometrioid 28 11 8 6 1 2 35–84 55 56.6 4 0 2 1 1 0 61–77 65 67.0
Mucinous 8 5 1 0 2 0 24–77 47.5 47.1 4 3 0 0 1 0 27–75 46.5 48.8
Other 16 3 1 5 5 2 25–75 60 56.8 6 2 0 1 2 1 37–84 62 61.2
Uterine disease 38 28–88 47 49.8 58 26–85 47 50.7
Uterine fibroids 5 35–70 40 44.8 17 28–66 46 46.2
Cervical cancer 18 7 7 0 1 3 28–65 40 42.8 15 11 3 0 0 1 26–70 46 47.6
Endometrial cancer 15 8 2 1 4 0 35–88 60 51.4 26 15 2 6 1 2 38–85 53 55.7
Other disease 0       5 33–66 60 55.4
Total 268 156

Abbreviations: EMS, endometriosis.